Search General Info
Search Education
Search Partnering Companies

Caroline Barelle, BSc, MBA, PhD

Aberdeen, United Kingdom
Caroline is CEO and co-founder of Elasmogen, a company that discovers and develops soloMER biologics for the treatment of inflammatory diseases and cancer. Before establishing Elasmogen, she successfully led teams at Wyeth and subsequently Pfizer in Global Bio-therapeutic Technologies progressing early platform technologies to late stage clinical development. Prior to this she was Alliance and Programs Manager at Haptogen Ltd and a key part of the acquisition team that successfully exited the business to Wyeth Inc. She has been awarded a prestigious Royal Society of Edinburgh Enterprise Fellowship, is a doctoral graduate from the University of Aberdeen in Biochemistry and an MBA (distinction) from Robert Gordon’s University, Business School. Caroline is a member of the Enterprise Skills and Strategy Board, is a Senior Associate for the Entrepreneurial Business School, Edinburgh, Entrepreneur in Residence for Queen’s University Belfast and sits on the BBSRC FoF and SFoF review panel.
Speaking In
[On Demand]
Elasmogen has developed a biologics platform based on antibody-like single domains called soloMERs…